Literature DB >> 32412906

Hepatitis B virus reactivation during direct-acting antiviral agent-based therapy for chronic Hepatitis C.

Ertuğrul Güçlü1, Sevgi Alan1, Oğuz Karabay1.   

Abstract

Entities:  

Year:  2020        PMID： 32412906      PMCID： PMC7236644          DOI： 10.5152/tjg.2020.18082

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN： 1300-4948            Impact factor:   1.852


× No keyword cloud information.
  5 in total

1.  Hepatitis due to Reactivation of Hepatitis B Virus in Endemic Areas Among Patients With Hepatitis C Treated With Direct-acting Antiviral Agents.

Authors:  Cheng Wang; Dong Ji; Jing Chen; Qing Shao; Bing Li; Jialiang Liu; Vanessa Wu; April Wong; Yudong Wang; Xiaoyong Zhang; Lei Lu; Chris Wong; Stella Tsang; Zheng Zhang; Jian Sun; Jinlin Hou; Guofeng Chen; George Lau
Journal:  Clin Gastroenterol Hepatol       Date:  2016-07-05       Impact factor: 11.382

2.  EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.

Authors: 
Journal:  J Hepatol       Date:  2017-04-18       Impact factor: 25.083

3.  Hepatitis B reactivation in patients with chronic hepatitis C undergoing anti-viral therapy with an interferon-free regimen.

Authors:  M-C Londoño; S Lens; Z Mariño; M Bonacci; X Ariza; T Broquetas; A Pla; C Bartres; M V Adriani; S Rodríguez-Tajes; J Costa; J A Carrión; S Pérez-Del-Pulgar; X Forns
Journal:  Aliment Pharmacol Ther       Date:  2017-02-16       Impact factor: 8.171

4.  Clinicopathologic features of dual chronic hepatitis B and C infection: a comparison with single hepatitis B, C and delta infections.

Authors:  Hakan Senturk; Veysel Tahan; Billur Canbakan; Faysal Dane; Yakup Ulger; Resat Ozaras; Fehmi Tabak; Gulsen Ozbay
Journal:  Ann Hepatol       Date:  2008 Jan-Mar       Impact factor: 2.400

5.  Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection.

Authors:  Chen-Hua Liu; Chun-Jen Liu; Tung-Hung Su; Yu-Jen Fang; Hung-Chih Yang; Pei-Jer Chen; Ding-Shinn Chen; Jia-Horng Kao
Journal:  Open Forum Infect Dis       Date:  2017-02-11       Impact factor: 3.835
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.